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Abstract
Background: Small interfering RNA (siRNA) against αENaC (α-subunit of the epithelial Na
channel) and CFTR (cystic fibrosis transmembrane conductance regulator) was used to explore
ENaC and CTFR function in newborn rat lungs.
Methods:  Twenty-four hours after trans-thoracic intrapulmonary (ttip) injection of siRNA-
generating plasmid DNA (pSi-0, pSi-4, or pSi-C2), we measured CFTR and ENaC expression,
extravascular lung water, and mortality.
Results: αENaC and CFTR mRNA and protein decreased by ~80% and ~85%, respectively,
following αENaC and CFTR silencing. Extravascular lung water and mortality increased after
αENaC and CFTR-silencing. In pSi-C2-transfected isolated DLE cells there were attenuated CFTR
mRNA and protein. In pSi-4-transfected DLE cells αENaC mRNA and protein were both reduced.
Interestingly, CFTR-silencing also reduced αENaC mRNA and protein. αENaC silencing, on the
other hand, only slightly reduced CFTR mRNA and protein.
Conclusion:  Thus, ENaC and CFTR are both involved in the fluid secretion to absorption
conversion around at birth.
Background
Fetal lungs are filled with fluid that is produced and
secreted by the pulmonary epithelium and linked to Na-
coupled Cl secretion in utero. This fluid must be rapidly
removed at birth for adequate gas exchange across the
alveolar epithelium-endothelium at birth to occur. Failure
to clear fetal lung fluid has been linked to preterm birth,
inherited genetic diseases, and inflammation and may
increase the risk of hypoxic injury to vital organs in new-
born infants; such injuries representing ~4% of infant
fatalities in 2002 [1].
Lung fluid absorption and secretion have been intensively
studied [2-7]. Apical amiloride-sensitive epithelial Na
channels (ENaC) [8,9] and basolateral Na,K-ATPases
[10,11] have been demonstrated as key proteins for vecto-
rial Na transport and lung fluid absorption. Recent studies
in fetal rats found an accelerated lung fluid absorption
between birth and 40 h postnatal age [12]. Lung Cl trans-
port is traditionally associated with fluid secretion during
lung development [2]. Studies of cultured alveolar type II
epithelial cells suggest that cystic fibrosis transmembrane
conductance regulator-(CFTR)-mediated Cl transport may
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also be involved [13,14]. There are, however, still some
questions to CFTR involvement since these studies rely on
cultured cells of uncertain phenotype and did not address
the possibility that fluid transport may involve multiple
different epithelial cell types, including alveolar epithelial
type I cells [15,16] and distal airway epithelial cells
[17,18]. In fact, the Na transport machinery involved in
lung fluid absorption as well as CFTR are present in both
alveolar epithelial type I and II cells [19].
ENaC and CFTR functions have been assessed in αENaC-/
- [8,20] and CFTR-/- [21] mice, but these results may be
confounded by various in vivo compensatory mecha-
nisms. In the present study, our first aim was to adapt and
use our recently developed RNA interference (RNAi) tech-
nique [9] to silence CFTR in newborn rats by trans-tho-
racic intrapulmonary (ttip) injection and to explore
functional in vivo responses to the CFTR-silencing. Thus,
we determined extravascular lung water and newborn
mortality after CFTR-silencing. Our second aim was to use
RNAi technology to silence CFTR in primary distal lung
epithelial cells (DLE cells) and to compare the effects with
the in vivo situation. Our third aim was to determine if
CFTR-silencing affected lung αENaC expression and if
αENaC silencing affected lung CFTR expression in vivo
and in vitro.
Materials and methods
Animals
Timed-pregnant Sprague-Dawley rats (wt 200–250 g, N =
28; Charles River, Wilmington, MA) were used in the
study. The rats were housed separately in their cages in a
temperature- and humidity-controlled environment (20 ±
2°C and 55 ± 10% relative humidity). The rats were kept
at a 12:12 h day-night rhythm and had free access to
standard rat chow (Purina, Copley Feed, Copley, OH) and
tap water. All studies were reviewed and approved by the
Institutional Animal Care and Use Committee (IACUC) at
the Northeastern Ohio Universities Colleges of Medicine
and Pharmacy, Rootstown, OH.
Plasmid construction
siRNA-generating plasmids were constructed using a com-
mercial plasmid (pSilencer 3.0-H1; Ambion, Austin, TX)
with standard techniques [22]. Selected recombinants
were sequenced (CEQ 2000XL; Beckman, Palo Alto, CA)
to verify correct oligonucleotide frames and sequences.
Plasmid DNA (pDNA) was amplified in Escherichia coli
DH5α and purified using the Wizard® PureFection pDNA
Purification System (Promega Co., Madison, WI). This
pDNA isolation kit has a specific resin-binding procedure
to remove endotoxin from the pDNA. After isolation and
purification, pDNA concentration and purity (ratio 1.7–
1.8) was measured at 260/280 nm and samples were
stored at -80°C.
CFTR
Rat CFTR mRNA [GenBank:XM_347229] secondary fold-
ing structure was predicted based on the principle of min-
imizing free energy, using RNA structure v. 3.71 software
[9]. Two 19-nucleotide regions from cDNA, 3872–3892
bp and 3458–3478 bp, were selected and designed as tar-
gets for rat CFTR specific siRNA-generating pDNA, named
pSi-C1 and pSi-C2, respectively. Each target sequence was
specific and did not match other sequences in the Gen-
Bank. For construction of siRNA-generating pDNA, two
complementary oligonucleotides (forward and reverse),
containing a sense strand, followed by a short spacer (5'-
TTCAAGAGA-3'), an antisense strand, and a RNA
polymerase III termination signal (5'-TTTTTTGGAAA-3'),
were synthesized, annealed, and ligated into pSilencer
3.0-H1. Synthesized oligonucleotides with BamHI and
HindIII overhangs were pSi-C1, forward 5'-
GATCCGTGGAGAGATGAAGAAATATTTCAAGA-
GAATATTTCTTCATCTCTCCATTTTTTGGAAA-3'  pSi-C1,
reverse 5'-
GCTTTTCCAAAAAATGGAGAGATGAAGAAATAT-
TCTCTTGAAATATTTCTTCATCTCTCCACG-3';  pSi-C2,
forward 5'-
ATCCGAAAGTATATGTACCAAGATTCAAGAGATCTTGG-
TACATATACTTTCTTTTTTGGAAA-3',  pSi-C2, reverse 5'-
AGCTTTTCCAAAAAAGAAAGTATATGTACCAA-
GATCTCTTGAATCTTGGTACATATACTTTCG-3'. As nega-
tive control we used a non-silencing sequence, 5'-
GATCCGTTACACTTTTTTGGAAA-3' (scramble, which
does not correspond to any known transcript) with
BamH1 and HindIII overhangs, also inserted in pSilencer
3.0-H1, named pSi-0.
αENaC
Rat  αENaC mRNA [GenBank:NM_031548] secondary
folding structure was also predicted based on the principle
of minimizing free energy as above. In our earlier study
[9], we generated four pDNA constructs named pSi-1 –
pSi-4 for αENaC silencing. Pilot studies [9] demonstrated
that pSi-4 was the most effective pDNA construct and was
selected for these studies. The pSi-4 sequence corresponds
to rat αENaC cDNA nucleotide positions 1617–1635, is
specific for rat αENaC and do not match other GenBank
sequences. For construction of siRNA-generating pDNA,
the same procedure as above was followed. The two oligo-
nucleotides were: pSi-4, forward: 5'-
GATCCGTTACACTATTAACAACAAATTCAAGAGATTT-
GTTGTTAATAGTGTAATTT TTTGGAAA-3', pSi-4, reverse:
5-AGCTTTTCCAAAAAATTACACTAT-
TAACAACAAATCTCTTGAATTTGTTGTTAATAG
TGTAACG-3'. We also used the same negative control,
pSi-0.Respiratory Research 2008, 9:55 http://respiratory-research.com/content/9/1/55
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Solutions
After measuring DNA concentration, the pDNA solution
was either concentrated by a vacuum centrifuge
(SVC100H; Savant Instrument Inc., Farmingdale, NY) or
diluted with sterile deionized water to the required con-
centration. pDNA solution osmolality was measured by a
Vapor Pressure Osmometer 5500 (Wescor Inc., Logan,
UT), and if needed adjusted with sterile NaCl or deionized
water to 100 mOsm. The pDNA solution was freshly pre-
pared by mixing pDNA containing either pSi-C1, pSi-C2,
pSi-4, or pSi-0 with Lipofectamine 2000™ (Invitrogen,
Carlsbad, CA), under optimized transfection conditions
[9]: pDNA (μg): Lipofectamine 2000™ (μl) ratio 1:1, gen-
erating a pDNA solution with the concentration 4 μg/g
body wt in a final volume of 40 μl/g body wt for each new-
born rat.
pDNA delivery
Timed-pregnant rats were observed for signs of labor and
delivery. Newborn rats were removed from the dams
within 1 h after birth. Freshly prepared pDNA/Lipo-
fectamine solution was delivered trans-thoracically via the
left pleural cavity to the lungs using a 30-G needle in a vol-
ume of 40 μl/g body wt [23]. Newborn rats were placed on
a 37°C temperature-controlled pad after pDNA injection.
The newborn rats were then allowed to recover in cages
with their respective dams where they remained for the
24-h study.
Specific protocols
All newborn rats were pretreated with scramble pDNA
(pSi-0), specific αENaC-silencing pDNA (pSi-4), or spe-
cific CFTR-silencing pDNA solution (pSi-C1 or pSi-C2) for
24 h as described above and divided into the following
groups. Mortality was recorded in all experimental
groups.  Untreated:  Newborn rat lungs were excised for
either extravascular lung water or RT-PCR and western
blot studies (N = 18). Pilot studies: For CFTR we tested the
two candidate sequences in newborn rats, pSi-C1 (N = 4)
and pSi-C2 (N = 4), and based on the efficiency data from
our pilot studies, we selected pSi-C2 as siRNA-generating
pDNA for CFTR. Control: Newborn rats were ttip injected
with irrelevant pDNA (pSi-0, N = 32). Lungs were excised
for either extravascular lung water or RT-PCR and western
blot studies. CFTR siRNA: Newborn rats were ttip injected
with CFTR siRNA-generating pDNA (pSi-C2,  N  = 63).
Lungs were excised for either extravascular lung water or
RT-PCR and western blot studies. αENaC siRNA: New-
born rats were ttip injected with αENaC siRNA-generating
pDNA (pSi-4, N  = 40). Lungs were excised for either
extravascular lung water or RT-PCR and western blot stud-
ies.
DLE cell isolation, culture, and RNAi localization
DLE cells were isolated from GD21 (GD = gestation day;
term = 22 days; N = 75 fetuses from 6 dams) rat fetuses
[24]. Briefly, dams were anesthetized with heparinized
(1,000 U) pentobarbital sodium (50 mg/kg body wt)
intraperitoneally and placed in temperature-controlled
environments. Rat fetuses were delivered one-by-one via
abdominal hysterotomy. Between deliveries the uterus
was kept closed by a non-injurious hemostat. Fetal lungs
and hearts were excised en bloc (heart was removed and
discarded) immediately after fetal decapitation. Lungs
from each litter were pooled, rinsed twice in ice-cold
HBSS (w/o Mg & Ca), and minced to <1 mm3. Fetal lung
tissue was digested in HBSS containing 0.125% trypsin
(Mediatech, Herndon, VA) and 25 μg/ml DNase I (MP
Biochemicals, Aurora, OH) 20 min at 37°C. After 20 min,
collagenase (USB Co., Cleveland, OH) and additional
DNase I were added to final concentrations of 0.1% and
50 μg/ml, respectively, and digestion was continued for
20 min. Enzymes were neutralized by adding 2 ml FBS
(fetal bovine serum; Atlanta Biologicals, Lawrenceville,
GA) at 4°C. Cell suspensions were transferred to new
tubes by tituration to break up cell clumps. Dispersed cell
solutions were filtered through 100 μm cell strainers (Bec-
ton Dickinson Labware, Franklin Lakes, NJ), and then
through 70 μm cell strainers. DLE cells were collected by
centrifugation (420 g; 6 min) and resuspended in 15 ml
DMEM/F-12 (Dulbecco's modified Eagle medium/F-12
50/50; Cellgro, Herndon, VA). The DLE cells were purified
by differential adherence steps. Cells were plated 2 × 30
min to remove fibroblasts. Cell yield was determined by a
Beckman Coulter Z1 Coulter particle counter. The purity
of the isolated DLE cells was on average 85–90% DLE
cells. Isolated DLE cells were seeded on 6-well plates
(Corning, Acton, MA) at 105 cells/cm2 densities. All cells
were submersion cultured in DMEM/F-12 with 10% FBS
in an atmosphere of 5% CO2, 21% O2, 74% N2 with 95%
humidity.
DLE cells were also isolated from newborn rats ttip
injected with pSi-0 or pSi-C2 (each N = 6) for 24 h. These
DLE cells were isolated following the same technique [24]
with some modifications. Lungs and hearts were excised
en bloc (heart was removed and discarded) immediately
after fetal decapitation. Blood was collected. Lungs from
each litter were pooled, rinsed twice in ice-cold HBSS (w/
o Mg & Ca), and minced to ~1 mm3. Lung tissue was then
processed as described above. For RNAi localization, cells
were collected by centrifugation 5 min at 1000 g and snap-
frozen in liquid nitrogen for down-stream analyses.
DLE cell transfection
Isolated DLE cells were transfected at 60%–80% conflu-
ency (1 day after plating) in 6-well plates using the pre-
pared pDNA/Lipofectamine solution according to theRespiratory Research 2008, 9:55 http://respiratory-research.com/content/9/1/55
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manufacturer. Each transfection solution contained 10 μg
of pDNA, pSi-C2, pSi-4, or pSi-0, and 10 μl Lipofectamine
2000™ in a total volume of 2 ml. After 6 h incubation, the
transfection solution was replaced with 10% FBS contain-
ing DMEM/F-12 medium. Twenty-four hours later, the
cells were lysed by appropriate lysis buffer depending on
down-stream analyses.
PCR
A polymerase chain reaction (PCR) was used to detect
pDNA after in vivo and in vitro pSi-0 transfection. Tem-
plate DNA was isolated from lung tissue, DLE cells, and
for control also kidney tissue using a DNA isolation kit
(Promega Co., Madison, WI). A primer pair was synthe-
sized targeting a pSi-0- specific sequence, pSi-0+: 5'-
CACTCGGATCCGTTACACTT-3', and pSi-0-: 5'-TAGTC-
CTGTCGGGTTTCG-3'. PCR was done with a PCR Master
Mix kit (Promega). Reaction volume was 25 μl, with 50 ng
of template DNA and 0.1 μM of each primer added, under
optimized conditions: 95°C 30 sec, 55°C for 30 sec, 72°C
for 1.5 min, for 30 cycles, and final extension for 5 min at
72°C. PCR amplification would yield a 127-bp pSi-0-spe-
cific fragment. PCR products were resolved in 1.5% agar-
ose gel containing 1 μg/ml ethidium bromide. Gels were
scanned by a Typhoon 8610 scanner (Molecular Dynam-
ics).
RT-PCR
Total RNA was extracted from lung tissue, isolated DLE
cells, and kidney tissue using a Versagene RNA isolation
kit from Gentra (Minneapolis, MN). RNA yield and purity
was determined spectrophotometrically at 260/280 nm
and RNA integrity was verified by agarose gel electro-
phoresis. A competitive reverse transcriptase polymerase
chain reaction (RT-PCR) was carried out using the One-
Step RT-PCR kit (EMD, San Diego, CA). Total reaction vol-
ume was 25 μl, containing 50 ng total RNA, 1 × PCR
buffer, 0.2 mM of each dNTP, 2.5 mM MgSO4, 0.1 μM of
each primer and 1.5 U rTth DNA polymerase. The RT-PCR
was optimized: 60°C 30 min reverse transcription, fol-
lowed by 40 cycles at 94°C 45 sec, 60°C 2 min, and final
extension 7 min at 60°C. We tested in preliminary exper-
iments 30 and 40 amplification cycles for pSi-4 [9]. We
elected to use 40 cycles after analysis of outcome versus
number of cycles and because we found that this amplifi-
cation generated repeatable results. Three primer pairs (+,
sense; -, antisense) were derived from GenBank
sequences, and synthesized for competitive RT-PCR:
αENaC  [GenBank:NM_031548], ENa+: 5'-CATGATG-
TACTGGCAGTTCGC-3' (731–751), ENa-: 5'-TCCCTT-
GGGCTTAGGGTAGAAG-3' (1751–1772); CFTR
[GenBank:XM_347229], CF+: 5'-ACTTACTTTGAAAC-
CCTATTCC-3' (3157–3178), CF-: 5'-AAGGCTTGTCTTA-
GAACTCG-3' (4102–4121); GAPDH
[GenBank:NM_017008], GAPD+: 5'-ACCACAGTCCAT-
GCCATCAC-3' (1369–1388), GAPD-: 5'-TCCACCAC-
CCTGTTGCTGTA-3' (1801–1820). Amplification of this
competitive RT-PCR yields a 1042-bp αENaC fragment, a
965-bp CFTR fragment, and a 452-bp GAPDH fragment
(internal control). RT-PCR products were resolved in
1.5% agarose gels stained with 1 μg/ml ethidium bro-
mide. Gels were scanned by a Typhoon 8610 Scanner.
Densitometric analysis was carried out with TotalLab soft-
ware (Nonlinear Dynamics Ltd, Newcastle upon Tyne,
U.K).
Western blot
Lung tissue or isolated DLE cells from newborn rats in
each experimental group was homogenized in T-Per™ Rea-
gent (Pierce, Rockford, IL) containing protease inhibitors,
aprotinin (30 μg/ml; Sigma, St. Louis, MO) and leupeptin
(1 μg/ml; Sigma), with a homogenizer (Tissue Tearor) on
ice. DLE cells were harvested in T-Per™ reagent and lysed
by sonication. The homogenate was centrifuged at 13,000
g for 5 min at +4°C. Supernatant (membrane and cytosol)
was collected, aliquoted in multiple vials, and snap-fro-
zen in liquid nitrogen. One vial was used for determining
total protein concentration of the sample to ensure equal
loading of the electrophoresis gel. Aliquots were stored at
-80°C until analyzed.
Polyacrylamide gel electrophoresis and transfer to nitro-
cellulose membranes (Pierce) were carried out using
standard protocols. After the polyacrylamide gel electro-
phoresis and transfer, the nitrocellulose membranes were
blocked (SuperBlock™ Dry Blend blocking buffer in tris
buffered saline (TBS); Pierce) for 1 h at room temperature.
After blocking, membranes were incubated with primary
antibodies on an orbital shaker over night at +4°C. Pri-
mary αENaC antibodies were purchased from Alpha Diag-
nostics International (San Antonio, TX; used at 1:1,000
dilution) and directed against N-termini of αENaC. The
antibodies recognize membrane proteins of appropriate
sizes (85–95 kDa) in rats. Primary CFTR antibodies were
bought from Santa Cruz Biotech, Inc. (Santa Cruz, CA;
used at 1:1,000 dilution) and directed against amino acids
1–182 mapping the CFTR N-terminus. The antibody rec-
ognizes a membrane protein of appropriate size (~150
kDa) in rats. Monoclonal anti-GAPDH antibodies
(GAPDH used as loading and transfer control; 1:1,000
dilution) were purchased from Cell Signaling Technology,
Inc. (Danvers, MA), detects GAPDH of rat origin, and
cross-reacts with guinea pig GAPDH (37 kDa). After incu-
bation, membranes were washed 5 × 10 min with wash
buffer (pH = 7.5; TBS with 0.1% Tween-20). Membranes
were incubated with HRP-conjugated secondary antibod-
ies (goat-anti-rabbit IgG; used at 1:1,000 dilution) for 1 h
at room temperature. After incubation, membranes were
washed again. Substrate solution (SuperSignal®  West
Femto; Pierce) was added and incubated for 5 min. TheRespiratory Research 2008, 9:55 http://respiratory-research.com/content/9/1/55
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luminescence signal was detected using a Kodak image
analyzer and densitometrically analyzed using TotalLab
software.
Extravascular lung water
To measure extravascular lung water in newborn rat lungs,
we modified the original method described previously
[25]. Extravascular lung water was measured in untreated
(N = 20), pSi-0-injected (N = 10), pSi-4-injected (N = 12),
and pSi-C2-injected (N = 15) newborn rats from 3–4 lit-
ters each. The lungs were rapidly excised, hearts removed,
and placed in pre-weighed sample tubes and re-weighed.
Water (250 μl) was added, lungs were weighed again, and
homogenized using a Tissue Tearor. If the extravascular
lung water determinations were not done the day of lung
harvest, collected lungs were weighed, water (250 μl)
added, and lungs were re-weighed and stored frozen at -
20°C until analysis. Parts of lung homogenates were cen-
trifuged 5 min at 14,000 g. Blood was collected from a
small number of newborn rats after decapitation to obtain
a hemoglobin (Hb) value for newborn rat blood. Hb con-
tent was measured on supernatants obtained after centrif-
ugation and blood volume of newborn rat lungs were
calculated from homogenate supernatant Hb concentra-
tion relative to blood Hb concentration. Newborn rat
blood wet-dry weight was determined. Lung wet-to-dry
weights were corrected for blood volume. Drying of lung
homogenates, lung homogenate supernatants, and new-
born rat blood was carried out using a moisture analyzer
(Sartorius, Edgewood, NY) that continuously recorded
water loss as samples dried. Each sample was dried at 80–
120°C until dry weights reached stability. Typically, this
procedure required 15 min/sample. Non-specific water
loss of wet samples and non-specific re-humidification of
dried samples, as may occur when small samples are
measured by traditional extravascular lung water tech-
niques, was prevented in this analysis. We verified the
technique by comparing it to traditional techniques [25]
in adult rat lungs.
Statistics
All data are presented as means ± SD. Data were analyzed
with one-way analysis of variance (ANOVA) with Tukey's
test as post hoc or Student's t test as appropriate. Differ-
ences were considered significant when P < 0.05.
Results
Lung CFTR mRNA during development
We determined if CFTR transcription changed during
early postnatal development. Lung total RNA from new-
born, 2-day-old (D), and adult rats were isolated. CFTR
mRNA was determined by RT-PCR. GAPDH was used as
internal control. CFTR transcription was ~2× higher in
newborn than in adult rats (Fig. 1). CFTR transcription
levels decreased during the first postnatal days and
reached adult levels on postnatal day 2.
We then investigated if the selected siRNA-generating
pDNA silenced CFTR both in vivo after ttip injection and
in vitro in isolated DLE cells to assure its functionality for
the further studies. We found that pSi-C2 was equally
effective under either optimized condition to silence
CFTR expression in both whole lung and DLE cells (Fig.
2AB).
RNAi for CFTR in newborn rat lungs and isolated DLE cells
We also carried out a comprehensive study to determine if
pSi-C2silenced CFTR in newborn rats. After ttip pSi-C2-
injection, as shown in Fig. 3A, CFTR mRNA was decreased
by ~80%. Western blot results demonstrated that pSi-C2
also decreased CFTR protein by ~80% (Fig. 3B). We then
investigated if CFTR-silencing affected αENaC expression.
As shown in Fig. 3A and Fig. 3B, CFTR-silencing also
reduced αENaC mRNA and protein.
We turned our attention to confirming this in isolated
DLE cells from rat fetuses. We therefore studied RNAi
silencing of CFTR in these isolated DLE cells after pSi-C2
pretreatment. DLE cells (isolated at GD21) were trans-
fected with the pDNA 1 day after cell plating. Twenty-four
hours after pDNA transfection, i.e., GD22 (birth), CFTR
and αENaC mRNA and protein were detected by RT-PCR
and western blot, respectively. As shown in Fig. 3C, pSi-
C2-transfection decreased CFTR mRNA by ~80%, com-
pared to pSi-0 transfected matched DLE cells. As seen in
Fig. 3D, western blot results emonstrate that, pSi-C2-trans-
fection also decreased CFTR protein by ~90%.
CFTR mRNA during early postnatal life of the rat to adult- hood Figure 1
CFTR mRNA during early postnatal life of the rat to 
adulthood. CFTR mRNA was measured by RT-PCR in lung 
tissue from newborn (NB), 2-day-old (2D), and adult rats. 
Representative RT-PCR gels are shown for lung CFTR and 
GAPDH (internal standard) mRNA.
<1 h 2D Adult
NB
GAPDH
CFTRRespiratory Research 2008, 9:55 http://respiratory-research.com/content/9/1/55
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RNAi for αENaC in newborn rat lungs and isolated DLE 
cells
We determined if pSi-4 silenced αENaC in the newborn
rats. After ttip pSi-4-injection, as shown in Fig. 4A, αENaC
mRNA was decreased by ~90%. Western blot results dem-
onstrated a decrease in αENaC protein by ~85% (Fig. 4B).
We then investigated if αENaC-silencing affected CFTR
expression; as shown in Figs. 4A and 4B, αENaC-silencing
slightly reduced CFTR mRNA and protein.
We then studied RNAi silencing of αENaC in isolated DLE
cells after pSi-4 pretreatment. DLE cells (isolated at
GD21) were transfected as above with the pDNA 1 day
after cell plating. Twenty-four hours after pDNA transfec-
tion, i.e., GD22 (birth), αENaC and CFTR mRNA and pro-
tein were detected by RT-PCR and western blot,
respectively. As shown in Fig. 4C, pSi-4-transfection
decreased αENaC mRNA by ~90%. As seen in Fig. 4D,
western blot results demonstrate that, pSi-4-transfection
also decreased αENaC protein by ~90%. Similar to the in
vivo situation, CFTR mRNA and protein were less affected
by the αENaC silencing.
Extravascular lung water
Extravascular lung water was measured as a functional
physiologic endpoint from ttip CFTR in vivo silencing. pSi-
0-injected newborn rats displayed the same extravascular
lung water as normal, untreated newborn rats. Extravascu-
lar lung water in ttip αENaC- and CFTR-silenced newborn
rat lungs were both significantly increased after siRNA-
generating pDNA injection (Fig. 5A).
Mortality from in vivo CFTR-silencing
We then studied if ttip pSi-0-, pSi-4, or pSi-C2-injection
affected newborn rat mortality. Newborn rats that died
within 1 h after ttip injection were excluded as injection-
related abnormalities (~3–4/litter irrespectively of experi-
mental group). When tabulated, newborn rats that died
after >1 h demonstrated the following mortality: pSi-0: 1
of 32 rats died, pSi-4: 9 of 40 rats died, and pSi-C2: 5 of 43
rats died. The data in Fig. 5B demonstrate mortality rates
of <3% in ttip pSi-0-injected newborn rats, ~23% in ttip
pSi-4-injected newborn rats, and ~12% in ttip pSi-C2-
injected newborn rats.
Localization of RNAi silencing
To determine in vivo and in vitro transfection ability of
pDNA during our conditions, we detected pSi-0 pDNA
lung and kidney presence by PCR. As shown in Fig. 6A,
there was a single clear band representing pSi-0 in both
ttip pSi-0-transfected lung tissue (equal strength in both
right and left lungs) and pSi-0-transfected DLE cells. The
same band was completely absent from the kidney sam-
ples, thus indicating no expression of our siRNA-generat-
ing pDNA (pSi-0) in this organ.
We also examined alveolar distribution of siRNA-generat-
ing pDNA 24 h after ttip pDNA injection for CFTR. DLE
cells were isolated from 6 pSi-0- and 6 pSi-C2-transfected
newborn rats. As can be seen in Fig. 6B, CFTR mRNA, as
determined by RT-PCR, was absent from isolated DLE
cells after ttip pSi-C2-injection.
CFTR mRNA in newborn rat lungs 24 h after ttip pSi-C2-injection (A) and CFTR mRNA in isolated DLE cells 24 h after pSi-C2- transfection (B) Figure 2
CFTR mRNA in newborn rat lungs 24 h after ttip pSi-C2-injection (A) and CFTR mRNA in isolated DLE cells 
24 h after pSi-C2-transfection (B). Representative RT-PCR gels are shown for lung CFTR and GAPDH (internal standard) 
mRNA.
CFTR
GAPDH
pSi-0     pSi-C2
CFTR
GAPDH
pSi-0      pSi-C2
ttip injection                   DLE cell transfection
A                                    BRespiratory Research 2008, 9:55 http://respiratory-research.com/content/9/1/55
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Organ specificity of RNAi silencing
To determine organ specificity of the RNAi silencing of
CFTR and αENaC in vivo in normal untreated newborn
rats and in newborn rats 24 h after ttip pSi-0, pSi-4, and
pSi-C2, we collected kidneys from these rats. In these kid-
neys, we determined if αENaC mRNA varied significantly
between our groups. As shown in Fig. 7, there were similar
expression of αENaC mRNA irrespectively which siRNA-
generating pDNA that was used.
Discussion
There were four important findings in our studies. First,
ttip injection of specific CFTR siRNA-generating pDNA
(pSi-C2) increased extravascular lung water and mortality
rate of newborn rats. Second, ttip pSi-C2-injection
decreased CFTR mRNA and protein in both in vivo new-
born rat lungs and isolated, pSi-C2-transfected DLE cells.
Third, CFTR-silencing by ttip pSi-C2-injection was spe-
cific. Fourth, ttip CFTR-silencing also reduced αENaC
mRNA and protein expression, thus suggesting involve-
ment of CFTR in regulation of ENaC at the conversion
from lung fluid secretion to fluid absorption near term.
Fifth, ttip αENaC silencing caused a slight reduction in
CFTR mRNA and protein expression, further supporting a
role for both proteins in the development of lung fluid
absorption mechanisms.
The majority of infants make the transition from intrau-
terine life to postnatal life without complications, but
only hours before birth, lungs are filled with an essentially
CFTR and αENaC mRNA (A) and protein (B) 24 h after ttip pSi-C2-injection in lung homogenate from newborn rats Figure 3
CFTR and αENaC mRNA (A) and protein (B) 24 h after ttip pSi-C2-injection in lung homogenate from new-
born rats. Representative RT-PCR gels and western blots are shown for lung homogenate CFTR, αENaC, and GAPDH 
(internal standard) mRNA and protein. CFTR and αENaC mRNA (C) and protein (D) 24 h after transfection of isolated and 
cultured DLE cells with pSi-C2. Representative RT-PCR gels and western blots are shown for DLE cell CFTR, αENaC, and 
GAPDH (internal standard) mRNA and protein.
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protein-free isosmolar solution that has been actively
secreted by the lung epithelium. The normal rate of lung
fluid absorption in newborn rats has been determined
earlier [12] and was not apparent before birth, reached a
high rate immediately after birth, and decreased to the
rate seen in adult rats by 40 h of newborn life. The molec-
ular mechanism responsible for perinatal lung fluid
absorption has been proposed to be ENaC, as mice defi-
cient in αENaC expression dies within 40 h of birth from
failure to clear fetal lung fluid [8]. mRNA for αENaC is
found earliest at GD19, while both β and γ subunits are
expressed at or after birth [26]. This expression patterns
agrees well with the observed amiloride-sensitivity and
function of fetal rat lungs at birth in the earlier study [12],
especially since ENaC requires all three subunits to
become fully functional. Recent studies have demon-
strated that failure in lung fluid absorption at birth may be
associated with ENaC deficiency [27-29]. In some cases,
such as congenital diaphragmatic hernia (CDH), ENaC
deficiency may have serious impact on lung fluid absorp-
tion at birth and drastically affect the ability to oxygenate
the newborn [29]. In our current study, silencing CFTR
with pSi-C2 was associated with elevated extravascular
lung water and an increased mortality rate, thus strength-
ening the assumption of CFTR being involved in the tran-
sition from fluid-filled fetal lungs to air-filled newborn
lungs at birth. ENaC and Cl transport proteins, such as
CFTR, are two important membrane components
expressed in the epithelial lining of lung alveoli [30]. An
earlier rat study has reported that fetal lung fluid absorp-
αENaC and CFTR mRNA (A) and protein (B) 24 h after ttip pSi-4-injection in lung homogenate from newborn rats Figure 4
αENaC and CFTR mRNA (A) and protein (B) 24 h after ttip pSi-4-injection in lung homogenate from newborn 
rats. Representative RT-PCR gels and western blots are shown for lung homogenate αENaC, CFTR, and GAPDH (internal 
standard) mRNA and protein. αENaC and CFTR mRNA (C) and protein (D) 24 h after transfection of isolated and cultured 
DLE cells with pSi-4. Representative RT-PCR gels and western blots are shown for DLE cell αENaC, CFTR, and GAPDH 
(internal standard) mRNA and protein.
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tion was mediated by βAR stimulation [12]. However, the
elevated lung fluid absorption rate in GD22 rat fetuses
was only minimally amiloride-sensitive and increased in
amiloride-sensitivity during the first 40 h of postnatal life
[12]. In the current study, we investigated how CFTR tran-
scription changed during early postnatal development.
CFTR maintained a relatively high expression at birth and
reached adult levels at the 2nd postnatal day.
In our earlier study [9], αENaC gene silencing in adult rat
lungs was achieved by siRNA generating pDNA, where the
pDNA was delivered conjugated with liposomal com-
plexes by intratracheal instillation. This method was orig-
inally developed by Folkesson and colleagues [31] and
took advantage of the anatomical characteristics of the
lung. To deliver pDNA in the original study [9] we utilized
a modification of the discoveries by Sawa and colleagues
[32], where they demonstrated that intraluminal water
instillation into the lung increased transfection efficiency.
However, this instillation technique is not suitable for
newborn rats due to their small size. It has been demon-
strated that DNA can be directly delivered to skeletal mus-
cle by intramuscular injection of 'naked' pDNA [33]. The
gene transfer was, however, restricted to muscle cells adja-
cent to the route of injection [33]. A more recent study by
Bhargava and colleagues [34] demonstrated that site-spe-
cific transient gene knockdown can be achieved by local
double-strand RNA hypothalamic injection. In our cur-
rent study, we modified the siRNA-delivery methods by
developing a repeatable ttip injection technique using a
pDNA (μg):liposome (μl) ratio 1:1 with a pDNA concen-
tration 4 μg/g body wt in a final volume of 40 μl/g body
wt and with a low osmolality of 100 mOsm. Our results
showed a reproducible specific siRNA-mediated αENaC
and CFTR-silencing, about ~80–85% for both mRNA and
protein, in newborn rat lungs by this method. In addition,
our method was organ specific and did not affect ENaC
expression in the kidney, another organ where ENaC is
highly expressed, nor did the pDNA itself reach the kid-
neys. We also demonstrated that our siRNA-generating
pDNAs did not reach the kidney after the ttip injections.
In our recent publication [23] using this technique, we
demonstrated the involvement of Nedd4-2 in ENaC
membrane regulation and the importance for newborn
lung conversion for fluid secretion to absorption in the
rat.
An additional limitation of our data might be that the
delivery of the siRNA-generating pDNAs invoked an inter-
feron and/or cytokine response. Since both ENaC and
CFTR can be affected by cytokines and interferons [35,36],
this could potentially explain the downregulation of
ENaC when the CFTR was silenced. However, for multiple
reasons we do not believe this to be the case. First, since
Extravascular lung water (A) in newborn rats 24 h after ttip pSi-0- and pSi-C2-injections compared to untreated normal new- born age-matched rats Figure 5
Extravascular lung water (A) in newborn rats 24 h after ttip pSi-0- and pSi-C2-injections compared to 
untreated normal newborn age-matched rats. Mortality (B) in newborn rats 24 h after ttip pSi-0- and pSi-C2-injections 
compared to untreated normal newborn age-matched rats.
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the interferon response is a response to the introduction
of a siRNA to the cells, pSi-0 should also have caused a
downregulation of ENaC and CFTR. This never occurred
in these or our earlier studies [9,23]. Second, albeit more
speculative, earlier studies suggest that introduction of
pure siRNA directly to the cells were more likely to cause
an interferon response than the introduction of siRNA-
generating pDNA or phage-mediated transfection [37-
39]. Third, all ENaC subunits, α-, β-, and γ, would likely
have been downregulated when αENaC was silenced had
there been an interferon response of significance. Fourth,
in our earlier study [23], when Nedd4-2 was silenced, the
expression of ENaC increased. Thus all this evidence
argues against that a major interferon and/or cytokine
response would be occurring in these studies.
As a functional endpoint, we evaluated changes in
extravascular lung water and mortality following ttip pSi-
C2. Interestingly, extravascular lung water was increased
after ttip pSi-C2-injection. Moreover, pSi-C2-injection
resulted in an increased mortality. These results indicate
that CFTR is involved in the transition from lung fluid
secretion to fluid absorption at birth. αENaC silencing
resulted in a similar increase in extravascular lung water,
with an even higher increase in mortality. The mortality
rate, however, was not the same as αENaC gene knockout
mice studies [8], possibly because the siRNA-generating
pDNA was administered after birth, in contrast to a gesta-
tional knockout. It may also be associated with the fact
that ttip pSi-4 and pSi-C2-injection only silenced αENaC
and CFTR in the lung and thus we avoided unspecific sys-
temic side-effects from αENaC and CFTR knockdown in
other organs, i.e., the GI tract. A third possibility is that
siRNA-mediated  αENaC and/or CFTR knockdown was
αENaC mRNA in normal untreated and 24 h after ttip pSi-0-, pSi-4-, and pSi-C2-injection in kidney homogenate from newborn  rats Figure 7
αENaC mRNA in normal untreated and 24 h after ttip pSi-0-, pSi-4-, and pSi-C2-injection in kidney homoge-
nate from newborn rats. A representative RT-PCR gel is shown for kidney homogenate αENaC mRNA. (BP: base pairs; M: 
marker)
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Localization of pSi-0 pDNA 24 h following ttip pSi-0-
injection in newborn rat lungs, in isolated DLE cells, 
and in the kidney (A) and identifying of the specific 
CFTR-silencing to the DLE cells 24 h after in vivo ttip 
administration (B). A representative RT-PCR gel is shown 
for lung CFTR and GAPDH (internal standard) mRNA. (BP: 
base pairs; M: marker; P: purified plasmid; RL: right lung; LL: 
left lung)
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incomplete and left residual αENaC and CFTR expression
in the lung. When a rescue model with CMV promoter-
driven rat αENaC expression in the -/- αENaC mouse lung
was utilized, a very low αENaC expression was encoun-
tered and this was apparently sufficient to rescue ~50% of
the mouse pups at birth [40]. The mortality may also be
attributable to that CFTR knockdown reduced αENaC
mRNA and protein by ~20–40%, since ENaC deficiency is
lethal.
Factors implied to regulate lung fluid absorption and
ENaC expression in the newborn include βAR agonists,
glucocorticoid hormones, thyroid hormones, and oxygen
concentrations [12,41-44]. Key Na transport proteins
involved are the basolateral Na,K-ATPase, that provides
the driving force, and ENaC provides an apical pathway
for Na entry into the epithelial cells [30]. Evidence has
been brought forward suggesting that ENaC activation
requires CFTR Cl channel function [45,46]. A number of
hypotheses have been presented how CFTR control ENaC
activity [47]. Research supports the hypotheses that there
are ENaC-CFTR interactions related to electrical coupling
of ion fluxes in epithelial cells [48]. Regulation of apical
Na channels (ENaC and other Na channels) has been
attributed to changes in cytosolic Ca, Cl concentration,
and pH [49]. Our results indicate that ENaC and CFTR
expression levels appear to correlate with each other at
this critical stage of lung development. However, if one is
affected by gene silencing (artificially or naturally by
mutation), a functional deficiency of this channel may
also affect the function/expression other channels. Poten-
tially this may be explained as that ion flow through the
channel, either partially or wholly, depends on the elec-
trochemical potential. Thus, when two channels are active
in the same membrane they would benefit from being
able to influence each other's expression/function. The
"electrical coupling" of Cl and Na conductances require
that these two conductances are expressed in parallel at
the apical epithelial cell membrane with a significant
impact on each other. Our results also suggest an "expres-
sion coupling" that support and may provide some
molecular background of the "electrical coupling"
between ENaC and CFTR.
Was this "expression coupling" between ENaC and CFTR
an "animal-only phenomenon" or could it be reproduced
in simpler system such as cell systems? To answer this
question we isolated and cultured DLE cells and trans-
fected them in vitro with pSi-4 or pSi-C2 pDNA. DLE cell
isolation was done on GD21 fetuses, transfection was
done 1 day later, and αENaC and CFTR expression meas-
ured after another day of incubation. We decided on this
protocol since it mimicked the time points when the new-
born rats were transfected in vivo. Transfection of DLE cells
with pSi-C2 resulted in a knockdown of CFTR, as observed
in the newborn rat in vivo. Moreover, when pSi-C2-trans-
fected cells were assayed for αENaC expression, we found
that αENaC mRNA and protein were all decreased, also as
observed in the newborn rats. Reversely, when the DLE
cells were transfected with pSi-4, αENaC expression was
decreased very significantly, while CFTR expression was
much less affected. Thus, the "ENaC-CFTR expression cou-
pling" was indeed present in the isolated DLE cells.
In conclusion, our data demonstrate by using selective
siRNA inhibition of CFTR expression that both CFTR and
ENaC are involved in the transition from lung fluid secre-
tion to lung fluid absorption at birth. Our data also sug-
gest that ENaC, being the principal agent stimulating lung
fluid absorption at birth, may possibly depend on CFTR
expression/function. Both CFTR and ENaC seem to be
interdependent to each other in order to generate the driv-
ing force for perinatal lung fluid absorption.
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